Related Experiment Videos
Second cancers among childhood survivors
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification.
European journal of cancer (Oxford, England : 1990)·2026
A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study.
European journal of cancer (Oxford, England : 1990)·2026
Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer.
European journal of cancer (Oxford, England : 1990)·2026
International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.
European journal of cancer (Oxford, England : 1990)·2026
Methodological considerations in the interpretation of ASCENT-03.
European journal of cancer (Oxford, England : 1990)·2026
Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4).
European journal of cancer (Oxford, England : 1990)·2026
Relationship between radiosensitivity of peripheral blood lymphocytes, breast cancer cells, and breast cancer stem cells in patients with breast cancer.
Biochemistry and biophysics reports·2026
A genome-wide association study on radiation induced fibrosis in breast cancer patients.
Clinical and translational radiation oncology·2026
Radiation dose comparison of photon-counting breast CT and mammography: A phantom study.
European journal of radiology open·2026
Safety profile of therapeutic radiopharmaceuticals for bone metastases pain palliation: evidence from a systematic literature review.
Nuclear medicine communications·2026